Design, Synthesis, and Biological Activity of NCC149 Derivatives as Histone Deacetylase 8‐Selective Inhibitors
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We recently discovered N‐hydroxy‐3‐[1‐(phenylthio)methyl‐1 H‐1,2,3‐triazol‐4‐yl]benzamide (NCC149) as a potent and selective histone deacetylase 8 (HDAC8) inhibitor from a 151‐member triazole compound library using a click chemistry approach. In this work, we present a series of NCC149 derivatives bearing various aromatic linkers that were designed and synthesized as HDAC8‐selective inhibitors. A series of in vitro assays were used to evaluate the newly synthesized compounds, four of which showed HDAC8 inhibitory activity similar to that of NCC149, and one of which displayed HDAC8 selectivity superior to that of NCC149. In addition, these top four compounds induced the increase of acetylated cohesin (an HDAC8 substrate) in HeLa cells in a dose‐dependent manner, indicating inhibition of HDAC8 in the cells. While none of these compounds enhanced the acetylation of H3K9 (a substrate of HDAC1 and 2), only one compound refrained from increasing α‐tubulin acetylation, a substrate of HDAC6, indicating that this compound is more selective for HDAC8 than the other derivatives. Furthermore, this HDAC8‐selective inhibitor suppressed the growth of T‐cell lymphoma cells more potently than did NCC149. These findings are useful for the further development of HDAC8‐selective inhibitors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These two aromatic hydroxamate derivatives show high selectivity for human HDAC8 (hHDAC8)”
From Characterization of Histone Deacetylase 8 (HDAC8) Selective Inhibition Reveals Specific Active Site Structural and Functional Determinants (2018) · cites this paper as [17]
Citations
Cites
Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds
Miyaura, N., & Suzuki, A. (1995) · Chemical Reviews · doi:10.1021/cr00039a007 · Cited by 12,817
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Acetylation and deacetylation of non-histone proteins
Glozak, M. A., Sengupta, N., Zhang, X., & Seto, E. (2005) · Gene · doi:10.1016/j.gene.2005.09.010 · Cited by 1,584
HDAC8 mutations in Cornelia de Lange syndrome affect the cohesin acetylation cycle
Deardorff, M. A., Bando, M., Nakato, R., Watrin, E., Itoh, T., Minamino, M., Saitoh, K., Komata, M., Katou, Y., Clark, D., et al. (2012) · Nature · doi:10.1038/nature11316 · Cited by 577
Self-citationBalasubramanian, S., Ramos, J., Luo, W., Sirisawad, M., Verner, E., & Buggy, J. J. (2008) · Leukemia · doi:10.1038/leu.2008.9 · Cited by 458
Second generation hybrid polar compounds are potent inducers of transformed cell differentiation.
Richon, V. M., Webb, Y., Merger, R., Sheppard, T., Jursic, B., Ngo, L., Civoli, F., Breslow, R., Rifkind, R. A., & Marks, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5705 · Cited by 420
Histone deacetylase 8 in neuroblastoma tumorigenesis
Oehme, I., Deubzer, H. E., Wegener, D., Pickert, D., Linke, J.-P., Hero, B., Kopp-Schneider, A., Westermann, F., Ulrich, S. M., von Deimling, A., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0684 · Cited by 398
Identification of Novel Isoform-Selective Inhibitors within Class I Histone Deacetylases
Hu, E., Dul, E., Sung, C.-M., Chen, Z., Kirkpatrick, R., Zhang, G.-F., Johanson, K., Liu, R., Lago, A., Hofmann, G., et al. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055541 · Cited by 347
Waltregny, D., Glénisson, W., Tran, S. L., North, B. J., Verdin, E., Colige, A., & Castronovo, V. (2005) · The FASEB Journal · doi:10.1096/fj.04-2303fje · Cited by 197
Design and evaluation of ‘Linkerless’ hydroxamic acids as selective HDAC8 inhibitors
KrennHrubec, K., Marshall, B. L., Hedglin, M., Verdin, E., & Ulrich, S. M. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.02.064 · Cited by 192
Research works printed but not linked: 1
- Yoshida M., 2003, Prog. Cell Cycle Res., 5, 269
Cited by
HDACs and HDAC Inhibitors in Cancer Development and Therapy
Li, Y., & Seto, E. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026831 · Cited by 1,284
HDAC8: a multifaceted target for therapeutic interventions
Chakrabarti, A., Oehme, I., Witt, O., Oliveira, G., Sippl, W., Romier, C., Pierce, R. J., & Jung, M. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.013 · Cited by 284
Inhibitors of histone deacetylase as antitumor agents: A critical review
Manal, M., Chandrasekar, M. J. N., Gomathi Priya, J., & Nanjan, M. J. (2016) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2016.05.005 · Cited by 216
Discovery of bioactive molecules from CuAAC click-chemistry-based combinatorial libraries
Wang, X., Huang, B., Liu, X., & Zhan, P. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.08.004 · Cited by 190
Next-generation of selective histone deacetylase inhibitors
Yang, F., Zhao, N., Ge, D., & Chen, Y. (2019) · RSC Advances · doi:10.1039/c9ra02985k · Cited by 155
Heimburg, T., Chakrabarti, A., Lancelot, J., Marek, M., Melesina, J., Hauser, A.-T., Shaik, T. B., Duclaud, S., Robaa, D., Erdmann, F., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01478 · Cited by 124
Marek, M., Shaik, T. B., Heimburg, T., Chakrabarti, A., Lancelot, J., Ramos-Morales, E., Da Veiga, C., Kalinin, D., Melesina, J., Robaa, D., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01087 · Cited by 122
Self-citationStrategies To Design Selective Histone Deacetylase Inhibitors
Melesina, J., Simoben, C. V., Praetorius, L., Bülbül, E. F., Robaa, D., & Sippl, W. (2021) · ChemMedChem · doi:10.1002/cmdc.202000934 · Cited by 118
Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview
Banerjee, S., Adhikari, N., Amin, S. A., & Jha, T. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.039 · Cited by 127
Targeting Histone Deacetylase 8 as a Therapeutic Approach to Cancer and Neurodegenerative Diseases
Chakrabarti, A., Melesina, J., Kolbinger, F. R., Oehme, I., Senger, J., Witt, O., Sippl, W., & Jung, M. (2016) · Future Medicinal Chemistry · doi:10.4155/fmc-2016-0117 · Cited by 111
Yang, E. G., Mustafa, N. B., Tan, E. C., Poulsen, A., Ramanujulu, P. M., Chng, W. J., Yen, J. J. Y., & Dymock, B. W. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00157 · Cited by 98
Heimburg, T., Kolbinger, F. R., Zeyen, P., Ghazy, E., Herp, D., Schmidtkunz, K., Melesina, J., Shaik, T. B., Erdmann, F., Schmidt, M., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01447 · Cited by 92
An Unbiased Approach To Identify Endogenous Substrates of “Histone” Deacetylase 8
Olson, D. E., Udeshi, N. D., Wolfson, N. A., Pitcairn, C. A., Sullivan, E. D., Jaffe, J. D., Svinkina, T., Natoli, T. E., Lü, X., Paulk, J., et al. (2014) · ACS Chemical Biology · doi:10.1021/cb500492r · Cited by 89
Development of a Potent and Selective HDAC8 Inhibitor
Ingham, O. J., Paranal, R. M., Smith, W. B., Escobar, R. A., Yueh, H., Snyder, T., Porco, J. A. J., Bradner, J. E., & Beeler, A. B. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00239 · Cited by 79
HDAC8 inhibition ameliorates pulmonary fibrosis
Saito, S., Zhuang, Y., Suzuki, T., Ota, Y., Bateman, M. E., Alkhatib, A. L., Morris, G. F., & Lasky, J. A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00551.2017 · Cited by 70
Self-citationStructure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
Luo, Y., & Li, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228828 · Cited by 62
Identification of a Novel Aminotetralin Class of HDAC6 and HDAC8 Selective Inhibitors
Tang, G., Wong, J. C., Zhang, W., Wang, Z., Zhang, N., Peng, Z., Zhang, Z., Rong, Y., Li, S., Zhang, M., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5008962 · Cited by 60
The Emerging Role of HDACs: Pathology and Therapeutic Targets in Diabetes Mellitus
Dewanjee, S., Vallamkondu, J., Kalra, R. S., Chakraborty, P., Gangopadhyay, M., Sahu, R., Medala, V. K., John, A. A., Reddy, P. H., Feo, V. D., et al. (2021) · Cells · doi:10.3390/cells10061340 · Cited by 71
Selective degradation of histone deacetylase 8 mediated by a proteolysis targeting chimera (PROTAC)
Chotitumnavee, J., Yamashita, Y., Takahashi, Y., Takada, Y., Iida, T., Oba, M., Itoh, Y., & Suzuki, T. (2022) · Chemical Communications · doi:10.1039/d2cc00272h · Cited by 59
Self-citationThe application of click chemistry in the synthesis of agents with anticancer activity
Sheng, J., Ma, N., Wang, Y., Ye, W., & Zhao, B. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s56038 · Cited by 65
Upadhyay, N., Tilekar, K. N., Jänsch, N., Schweipert, M., Hess, J. D., Macias, L. G.-F., Mrówka, P., Aguilera, R. J., Choe, J., Meyer‐Almes, F., et al. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.103934 · Cited by 56
Synthesis and applications of benzohydroxamic acid-based histone deacetylase inhibitors
Vreese, R. D., & D’hooghe, M. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.04.013 · Cited by 58
Debnath, S., Debnath, T., Bhaumik, S., Majumdar, S., Kalle, A. M., & Vema, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-53376-y · Cited by 52
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Fontana, A., Cursaro, I., Carullo, G., Gemma, S., Butini, S., & Campiani, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710014 · Cited by 50
Darwish, S., Ghazy, E., Heimburg, T., Herp, D., Zeyen, P., Salem-Altintas, R., Ridinger, J., Schmidtkunz, K., Robaa, D., Erdmann, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147535 · Cited by 48
Small molecules as tools to study the chemical epigenetics of lysine acetylation
Schiedel, M., & Conway, S. J. (2018) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2018.06.015 · Cited by 47
Amin, S. A., Adhikari, N., & Jha, T. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0130 · Cited by 45
Discovery of meta-sulfamoyl N-hydroxybenzamides as HDAC8 selective inhibitors
Zhao, C., Zang, J., Ding, Q., Inks, E. S., Xu, W., Chou, C. J., & Zhang, Y. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.002 · Cited by 40
Class I HDAC Inhibitors: Potential New Epigenetic Therapeutics for Alcohol Use Disorder (AUD)
Bourguet, E., Ozdarska, K., Moroy, G., Jeanblanc, J., & Naassila, M. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00115 · Cited by 36
Amin, S. A., Khatun, S., Gayen, S., Das, S., & Jha, T. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115594 · Cited by 34
Significance of Five-Membered Heterocycles in Human Histone Deacetylase Inhibitors
Frühauf, A., Behringer, M., & Meyer‐Almes, F. (2023) · Molecules · doi:10.3390/molecules28155686 · Cited by 42
Drugging the Schistosome Zinc-Dependent HDACs: Current Progress and Future Perspectives
Marek, M., Oliveira, G., Pierce, R. J., Jung, M., Sippl, W., & Romier, C. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.25 · Cited by 33
HDAC8 regulates neural differentiation through embryoid body formation in P19 cells
Katayama, S., Morii, A., Makanga, J. O., Suzuki, T., Miyata, N., & Inazu, T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.02.195 · Cited by 28
Self-citationHan, M. İ., & Küçükgüzel, Ş. G. (2021) · Current Drug Targets · doi:10.2174/1389450122666210614121237 · Cited by 25
Itoh, Y., Zhan, P., Tojo, T., Jaikhan, P., Ota, Y., SUZUKI, M. T., Li, Y., Hui, Z., Moriyama, Y., Takada, Y., et al. (2023) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c01095 · Cited by 27
Self-citationTargeting SMAD-Dependent Signaling: Considerations in Epithelial and Mesenchymal Solid Tumors
Runa, F., Ortíz-Soto, G., de Barros, N. R., & Kelber, J. A. (2024) · Pharmaceuticals · doi:10.3390/ph17030326 · Cited by 26
Kashyap, K., & Kakkar, R. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1567388 · Cited by 20
Kashyap, K., & Kakkar, R. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1711191 · Cited by 17
Castañeda, C. A., López, J. E., Joseph, C. G., Scholle, M. D., Mrksich, M., & Fierke, C. A. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00851 · Cited by 15
Kashyap, K., & Kakkar, R. (2020) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2020.103850 · Cited by 18
Itoh, Y. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00741 · Cited by 15
Self-citationBanerjee, S., Amin, S. A., Adhikari, N., & Jha, T. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1704881 · Cited by 13
HDAC8 As an Emerging Target in Drug Discovery With Special Emphasis on Medicinal Chemistry
Rajaraman, S., Balakrishnan, R., Deshmukh, D., Ganorkar, A., Biswas, S., Pulya, S., & Ghosh, B. (2023) · Future Medicinal Chemistry · doi:10.4155/fmc-2023-0054 · Cited by 16
Novel HDAC8 inhibitors: A multi-computational approach
Manal, M., Manish, K. K., Sanal, D., Ayyamperumal, S., Devadasan, V., & Chandrasekar, M. (2017) · SAR and QSAR in environmental research · doi:10.1080/1062936x.2017.1375978 · Cited by 13
Applications of Click Chemistry in Drug Discovery and Development
Gopalan, B., & Balasubramanian, K. K. (2016) · doi:10.1002/9783527694174.ch2 · Cited by 13
Vema, A., Debnath, S., & Kalle, A. M. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.103863 · Cited by 12
Nurani, A., Yamashita, Y., Taki, Y., Takada, Y., Itoh, Y., & Suzuki, T. (2024) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c23-00577 · Cited by 12
Self-citationMorii, A., Katayama, S., & Inazu, T. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00091 · Cited by 10
Jänsch, N., Lang, K. L., & Meyer‐Almes, F. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911775 · Cited by 9
Transcription regulation mechanism of the syntaxin 1A gene via protein kinase A
Nakayama, T. W., & Akagawa, K. (2017) · Biochemical Journal · doi:10.1042/bcj20170249 · Cited by 9
Lowe, B. D., & Fletcher, S. (2025) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2025.130312 · Cited by 6
Discovery of novel HDAC8 inhibitors from natural compounds by in silico high throughput screening
Rubavathy, S. M. E., Palanisamy, K., Priyankha, S., Thilagavathi, R., Prakash, M., & Selvam, C. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2022.2142668 · Cited by 5
Khatun, S., Islam, R., Amin, S. A., Bhattacharya, A., Dhaked, D. K., Jha, T., & Gayen, S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2442756 · Cited by 5
Peng, Y., Gao, Q., Wang, Y., Yao, Q., & Zhang, J. (2021) · ChemMedChem · doi:10.1002/cmdc.202001004 · Cited by 4
Targeting cancers and metabolic disorders: The prospects of combining HDAC8 inhibitor and activator
Yusif, M. M. (2022) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2022.100097 · Cited by 5
Recently Reported Ru-Metal Organic Coordination Complexes and Their Application (A Review)
Guin, P. S., & Roy, S. (2022) · Russian Journal of General Chemistry · doi:10.1134/s1070363222080242 · Cited by 3
Synthesis of New 1,3-Thiazolecarbaldehydes
Sinenko, V. O., Slivchuk, S. R., Mityukhin, O. P., & Броварец, В. С. (2017) · Russian Journal of General Chemistry · doi:10.1134/s1070363217120039 · Cited by 2
Chotitumnavee, J., Seemaung, P., Settacomkul, R., Sukprasert, R., Itoh, Y., Suzuki, T., Srihirun, S., Power, C., & Vivithanaporn, P. (2026) · Drug Design Development and Therapy · doi:10.2147/dddt.s555228 · Cited by 2
Self-citation2.5 CuAAC and Metal-Free 1,3-Dipolar Huisgen Cycloadditions in Drug Discovery
Kacprzak, K. M., Skiera, I., & Rutkowski, J. (2021) · Haug Verlag in Georg Thieme Verlag KG eBooks · doi:10.1055/sos-sd-235-00082 · Cited by 1
Molecular Technology for Epigenetics Toward Drug Discovery
Suzuki, T. (2019) · Wiley eBooks · doi:10.1002/9783527823987.vol2_c11 · Cited by 1
Self-citationThe Specificity and Regulation of Human Histone Deacetylase 8.
Pitcairn, C. A. (2015) · Deep Blue (University of Michigan)
Target Identification of HDAC8 Isoform for the Treatment of Cancer
Umamaheswari, A., Puratchikody, A., & Balasubramaniyan, S. (2018) · Advances in medical technologies and clinical practice book series · doi:10.4018/978-1-5225-7326-5.ch007
Progress in the Research of Selective Histone deacetylase Inhibitors
张, 立. (2021) · Advances in Material Chemistry · doi:10.12677/amc.2021.91002
Combinatorial Chemistry Online Volume 16, Issue 5, May 2014
Terrett, N. K. (2014) · Combinatorial Chemistry - an Online Journal · doi:10.1016/j.comche.2014.04.001
Ramos‐Morales, E. (2021) · theses.fr (ABES) · doi:10.70675/c6b28473zf6b6z4024z99bfz05629f0484d7
Yu, S., Itoh, Y., & Suzuki, T. (2026) · Chemistry Letters · doi:10.1093/chemle/upag134
Self-citationAntypenko, L., Antypenko, O., Kozak, Y., Саліонов, В. О., Maletskyi, M., Лисянська, Г. П., & Kovalenko, S. (2026) · Research Square · doi:10.21203/rs.3.rs-10243724/v1
Wang, W., Shayilan, N., Qi, X., & Ma, C. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119315
Chen, J., Wang, W., Qi, X., Shayilan, N., Weiyi, Z., & Ma, C. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c01456
BindingDB (2016) · UC San Diego · doi:10.7270/q29c700v
BindingDB Entry 50010003: Development of a Potent and Selective HDAC8 Inhibitor.
BindingDB (2021) · UC San Diego · doi:10.7270/q2qc0718
BindingDB (2020) · UC San Diego · doi:10.7270/q2125w99
BindingDB (2019) · UC San Diego · doi:10.7270/q2g44sqs
Metadata
- Authors
- Suzuki, T., Muto, N., Bando, M., Itoh, Y., Masaki, A., Ri, M., Ota, Y., Nakagawa, H., Iida, S., Shirahige, K., & Miyata, N.
- Affiliations
- Nagoya City University (JP)
- Institute for Quantitative Biosciences, The University of Tokyo (JP)
- Kyoto Prefectural University of Medicine (JP)
- Corresponding author
- Suzuki, Takayoshi
- Miyata, Naoki
- ORCID
- Venue
- ChemMedChem
- Publisher
- Wiley
- Published
- 2014-01-08
- Volume
- 9
- Issue
- 3
- Pages
- 657-664
- ISSN
- 1860-7179 (ISSN-L)
- 1860-7187
- OpenAlex
- W2148310814
- Cited by
- 71
- References
- 26
- Citations by year
- 2026: 5 · 2025: 2 · 2024: 4 · 2023: 4 · 2022: 8 · 2021: 7 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 8 · 2016: 7 · 2015: 5 · 2014: 3
- FWCI
- 3.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- ChemMedChem (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (24659050, 24689007)
- Precursory Research for Embryonic Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Physical Sciences › Chemistry › Organic Chemistry › Click Chemistry and Applications
- Physical Sciences › Chemistry › Organic Chemistry › Heterocyclic Compound Synthesis and Bioactivity
- Keywords
- HDAC8 inhibitors, HDAC8, triazole derivatives, aromatic linkers, H3K9 acetylation, alpha-tubulin acetylation, T-cell lymphoma, enzyme selectivity
- MeSH terms
- Antineoplastic Agents, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, HeLa Cells, Histone Deacetylases, Humans, Hydroxamic Acids, Repressor Proteins, Structure-Activity Relationship, Triazoles, Drug Design, Molecular Structure, Cell Line, Tumor, Cell Proliferation, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.